ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Defining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction culture.

Emerson et al.
Papers
PLOS ONE
November 2014
Authors and Affiliates
Emerson RO1, Mathew JM2, Konieczna IM3, Robins HS4, Leventhal JR3. 1Adaptive Biotechnologies Corporation, Seattle, Washington, United States of America. 2Department of Surgery, Comprehensive Transplant center, Northwestern University, Chicago, Illinois, United States of America; Department of Microbiology-Immunology, Northwestern University, Chicago, Illinois, United States of America. 3Department of Surgery, Comprehensive Transplant center, Northwestern University, Chicago, Illinois, United States of America. 4Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.